Vaccins et dispositifs d'administration

Thèmes

Hot Topics cover page template

Organisé par: Alexandre Paulo

COVID-19 Vaccine Label: User Evaluation

Organisé par: Jacqueline Deelstra

Delivery technology – technical resources

Organisé par: David Brown

Dose Per Container: Understanding the Effects of Multidose Vaccine Presentations

Organisé par: Kelly McDonald

Voir tous les Thèmes

Du Centre de Connaissances

On the verge of RSV disease prevention: A communications toolkit

Sample supportive supervision questions (Appendix: Guide for introducing a malaria vaccine)

Note de synthèse: position de l’OMS sur les vaccins antiourliens - mars 2024

WHO Prequalification - R21 Malaria

Auteur: Anand Anbarasu, Paul Livingstone, Sudha Ramaiah, Reetika Debroy, Gayathri Ashok, Soumya Basu

Success story: Strengthening new vaccine introductions in Lesotho

Auteur: Samir V. Sodha, Ananya Iyengar, Arindam Ray, Iqbal Hossain, Daniel Ali, Ibrahim Dadari, Niklas Danielsson, Rachel V. Belt

Feuille de route de l’OMS concernant l’utilisation des vaccins contre la COVID-19 dans le contexte des variants Omicron et d’une forte immunité collective

Auteur: Kirsten Ward

EXPÉRIENCE DU CAMBODGE EN MATIÈRE DE VACCINATION CONTRE LA COVID-19 ET DE DÉPISTAGE DES MALADIES NON TRANSMISSIBLES

Auteur: UNICEF, World Health Organization (WHO)

MCV 5-dose vial assessment support tool

Leveraging micro-array patch (MAP) technology for vaccine delivery - TechNet Conference 2023

Auteur: World Health Organization (WHO)

WHO news release - R21/Matrix-M malaria vaccine recommendation

Auteur: Rebecca Alban, Tafwirapo Chihana, Chifuniro Chiyendausiku

WHO prequalification - Mosquirix (RTS,S/AS01)

Auteur: The ROTA Council

Malaria vaccine - questions and answers

Auteur: World Health Organization (WHO)

Full evidence report on the R21/Matrix-M malaria vaccine

Full evidence report on the RTS,S/AS01 malaria vaccine

Auteur: Noni MacDonald, Dalhousie U.

WHO Guidelines for malaria

Auteur: Lee Hall

Malaria vaccine - WHO position paper

Auteur: World Health Organization (WHO)

The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia

Auteur: World Health Organization (WHO)

Gavi Product Menu

UNICEF Pricing Information-MCV

Auteur: Laura Nic Lochlainn

UNICEF Pricing Information-MMR

Auteur: Barney Graham

UNICEF Pricing Information-MR

Auteur: Charlie Weller

UNICEF Pricing Information-HPV

Auteur: Peter Dull, Sinead Delany-Moretlwe

UNICEF Pricing Information-RVV

Auteur: Abdul Momin Kazi

UNICEF Pricing Information-PCV

Auteur: Alejandro Cravioto, Shahida Baqar

Acceptability and feasibility of delivering pentavalent vaccines in a compact, prefilled, autodisable device in Vietnam and Senegal

Auteur: Philippe-Alexandre Gilbert

Vaccine adjuvants

Auteur: Raman Rao, Jessica Martinez

Experience and challenges from clinical trials with malaria vaccines in Africa

Auteur: Melanie Saville

Sudden unexpected deaths and vaccinations during the first two years of life in italy: A case series

Auteur: Annie Mo, Jerome Kim

Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period

Auteur: Martin Friede

Immunogenicity, safety, and tolerability of a hexavalent vaccine in infants

Auteur: Sue Ann Clemens, Max Silverman

Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study

Auteur: Ruth Karron, Carolyn Deal

Safety and immunogenicity of two doses of quadrivalent meningococcal conjugate vaccine or one dose of meningococcal group C conjugate vaccine, both administered concomitantly with routine immunization to 12- to 18-month-old children

Auteur: World Health Organization (WHO)

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial

Auteur: Mathias Garny

Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh

Auteur: Melkamu Ayalew

Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus Calmette-Guérin (BCG) vaccines from different sources, Kazakhstan

Auteur: VillageReach

Hepatitis B virus infection in northern Uganda: Impact of pentavalent hepatitis B vaccination

Auteur: VillageReach

Risk in vaccine research and development quantified

Auteur: VillageReach

Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach

Auteur: VillageReach

Prevention and control of meningococcal outbreaks: The emerging role of serogroup B meningococcal vaccines

Auteur: VillageReach

Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study

Auteur: VillageReach

Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children

Auteur: Chang-Yuil Kang

Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders

Auteur: Timothy Chege

Innovation partnership for a roadmap on vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow

Auteur: Josphat Kiprop Kosgei

Disparate adjuvant properties among three formulations of “alum”

Auteur: Chul Kim

An evaluation of emerging vaccines for childhood meningococcal disease

Auteur: Dal-Hee Min

High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses

Auteur: Mohammad Mamun Alam

Exploring new packaging and delivery options for the immunization supply chain

Auteur: Debasu Damtie

Use of oral cholera vaccines in an outbreak in Vietnam: A case control study

Auteur: Hitt Sharma

OPTIMIZAÇÃO DO ESQUEMA DE VACINAÇÃO ANTI-VPH Principais considerações para a tomada de decisões, a programação e a implementação

Auteur: Peter Dull

OPTIMIZACIÓN DEL ESQUEMA DE LA VACUNA CONTRA EL VPH Aspectos clave para la toma de decisiones, planificación e implementación

Auteur: Michelo Simuyandi

HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation

Auteur: Ruth Karron

OPTIMISATION DU SCHÉMA DE VACCINATION ANTI-VPH Principales considérations en matière de prise de décision, de planification et de mise en œuvre

Auteur: Annelies Wilder-Smith

HPV VACCINE SCHEDULE OPTIMIZATION — KEY CONSIDERATIONS FOR DECISION-MAKING, PLANNING AND IMPLEMENTATION

Auteur: Jessica Fleming

ОПТИМИЗАЦИЯ СХЕМЫ ИММУНИЗАЦИИ ПРОТИВ ВПЧ - ОСНОВНЫЕ МОМЕНТЫ, НА КОТОРЫЕ НЕОБХОДИМО ОБРАТИТЬ ВНИМАНИЕ ПРИ ПРИНЯТИИ РЕШЕНИЙ, ПЛАНИРОВАНИИ И

Auteur: Cathy Ndiaye

How to use a bifurcated needle to perform multiple puncture vaccination technique

Auteur: Halidou Tinto

DTaP-IPV-Hep B-Hib Vaccine (Hexaxim(®)): a review of its use in primary and booster vaccination

Auteur: Alexander Rowe

Pertussis vaccines: WHO position paper, August 2015-Recommendations.

Auteur: Hani Kim

Hepatitis B vaccine in healthy hospital employees

Auteur: Alice Chen

Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine

Auteur: Peter Andersen

Overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis

Auteur: Darin Edwards

Applying mathematical tools to accelerate Vaccine Development: modeling shigella immune dynamics

Auteur: Chunlin Xin

Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability

Auteur: Michael Egan

Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases

Auteur: Peter Openshaw

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions

Auteur: Melanie Saville

Indian vaccine innovation: the case of Shantha Biotechnics

Auteur: Melanie Saville

Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-olds

Auteur: Nathalie Garcon

Demographic Health Survey (DHS), Multiple Indicators Cluster Survey (MICS)

Auteur: Marta Tufet

Accurate prediction of vaccine stability under real storage conditions and during temperature excursions

Auteur: Mahima Datla

Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanus

Auteur: Patrick Tippoo

Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines

Auteur: Jerry Sadoff

A novel single-dose dengue subunit vaccine induces memory immune responses

Auteur: Harry Kleanthous

Lyophilization of adjuvanted vaccines: Methods for formulation of a thermostable freeze-dried product

Auteur: Tarun Saluja

Cold chain and virus-free chloroplast-made booster vaccine to confer immunity against different poliovirus serotypes

Auteur: Mindy Miner

Prevention of pneumococcal diseases in the post-seven valent vaccine era: A European perspective

Auteur: Anna Seale

Vaccine against tuberculosis: what’s new?

Auteur: Arnaud Didierlaurent

Technical development of a new meningococcal conjugate vaccine

Auteur: Rudzani Muloiwa

Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: The ProVac experience

Auteur: Deborah Watson-Jones

Effect of age at vaccination on rotavirus vaccine effectiveness in Bolivian infants

Auteur: Andrew Pollard

Economic impact of thermostable vaccines

Auteur: Naor Bar-Zeev

Economic value of dengue vaccine in Thailand

Auteur: Kristen Earle

Is the world ready for an Ebola vaccine?

Auteur: Rachel Park

Improving global access to new vaccines: Intellectual property, technology transfer, and regulatory pathways

Auteur: Ana Jaklenec

A rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primates

Auteur: Jean-Pierre Amorij

Meningococcal vaccines: from polysaccharide to conjugate vaccines

Auteur: Hadley Ikwe

New studies of BCG: implications for tuberculosis vaccines

Auteur: Amaya Gillespie

Evidence of reduction in HPV infection and CIN2+ after vaccine introduction in Scotland

Auteur: Julie Leask

Assessing the potential cost-effectiveness of microneedle patches in childhood measles vaccination programs: The case for further research and development

Auteur: Lisa Menning

The use of a placebo in vaccine trials

Auteur: C. Edson Utazi

Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: A randomized controlled trial

Auteur: Samir Sodha

Peptide vaccination is superior to genetic vaccination using a recombineered bacteriophage λ subunit

Auteur: Jean-Pierre Amorij

Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept

Auteur: David Bloom

Long-term evaluation of mucosal and systemic immunity and protection conferred by different polio booster vaccines

Auteur: Richard White

Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?

Auteur: Mark Jit

Vaccine pipeline has grown during the past two decades with more early-stage trials from small and medium-size companies

Auteur: Punnee Pitisuttithum

Intranasal immunization with dry powder vaccines

Auteur: Shan Lu

A vaccine against serogroup B Neisseria meningitidis: dealing with uncertainty

Auteur: Mark Hatherill

Effects of freezing on DPT and DPT-IPV vaccines, adsorbed

Auteur: Annie Mo

Introducing cholera vaccination in Asia, Africa and Haiti: A meeting report

Auteur: Barney Graham

Emerging vaccine technologies

Auteur: World Health Organization (WHO)

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign

Auteur: Tonya Villafana

Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems

Auteur: Gustavo Santos

Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperatures

Auteur: Melanie Saville

Data at WHO

Auteur: Ana Maria Henao Restrepo

Presentation on Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care

Auteur: Birgitte Giersing

Economic costs of Rotavirus disease and the value of vaccines

Auteur: Kwaku Poku Asante

Le vaccin antipaludique RTS,S

Auteur: Helen Matzger

The RTS,S Malaria Vaccine

Auteur: Lee Hall

WHO SAGE roadmap on uses of COVID-19 vaccines in the context of OMICRON and substantial population immunity

Auteur: Noni MacDonald

Guidance to support programmes and partners to assess and address behavioural and social drivers (BeSD) of vaccination

Auteur: Jerome Kim

Guidance for the implementation and evaluation of strategies to increase vaccine demand and uptake

Auteur: Hee-Chang Jang

VIEW-hub by IVAC

Auteur: Lee Hall

The ROTA Council

Auteur: Stephanie Shendale, Séraphin Kouassi, Messeret Zelalem, Sié Kabran Kouadio, Melkamu Ayalew, Kibrom Abraham, Yohannes Lakew, Fatoumata Kone

HPV Information Centre

Auteur: GVIRF Secretariat

Good practice statement on the use of variant-containing COVID-19 vaccines

Auteur: Covid-19 Vaccine Delivery Partnership

Recomendaciones provisionales para el uso de la vacuna de Valneva (‎VLA2001)‎ contra la COVID-19: orientaciones provisionales, versión inicial: 18 de agosto de 2022

Auteur: World Health Organization (WHO), HECAF360

WHO position papers

Auteur: HECAF360

Bolivia - Informe Evaluación Post-introducción de Vacunas contra COVID-19 (mini cPIE)

Auteur: Francine Ganter-Restrepo

Case study: Rwanda - Monitoring Approaches_FR

Auteur: Lisa Menning

Case Study: Rwanda - Monitoring Approaches

Auteur: International Vaccine Access Center (IVAC)

India - Déploiement du vaccin contre la COVID-19 et outils numériques

Auteur: The ROTA Council

RDC - Ecouter et Agir les plus vulnerables - Croix Rouge RDC

Auteur: HPV Information Centre

The Gambia - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: World Health Organization (WHO)

Guidance on an adapted evidence to recommendation process for National Immunization Technical Advisory Groups

Auteur: World Health Organization (WHO)

Single Dose HPV vaccine Evidence master slides

Auteur: The Coalition against Typhoid (CaT) and the Typhoid Vaccine Acceleration Consortium (TyVAC)

Comparison table of WHO prequalified typhoid conjugate vaccines (TCVs)

Auteur: World Health Organization (WHO)

Typhoid burden of disease and potential benefits of new typhoid conjugate vaccines (TCVs)

Auteur: World Health Organization (WHO)

Human papillomavirus vaccines: WHO position paper (‎2022 update)‎

Auteur: Alba Vilajeliu, Gladys Benavides Abella, Boravy El

Vaccins contre les papillomavirus humains: note de synthèse de l’OMS (‎mise à jour de 2022)‎

Auteur: World Health Organization (WHO)

2021-10-14 mRNA Vaccine Technologies for Global Health - AGENDA

Auteur: JSI Research & Training Institute

2021-10-14 mRNA Vaccine Technologies for Global Health - VIDEO

Auteur: Chương trình Tiêm chủng Mở rộng Quốc gia, PATH

2021-10-14 mRNA Vaccine Technologies for Global Health - PRESENTATIONS

Auteur: Chương trình Tiêm chủng Mở rộng Quốc gia, PATH

2022-03-03 Malaria Vaccine R&D and Immunization: Lessons Learned and Considerations for Global Health Impact - AGENDA

Auteur: Chương trình Tiêm chủng Mở rộng Quốc gia, PATH

The ebola vaccine, iatrogenic injuries, and legal liability

Auteur: JSI

The 2016 Vaccine Development Pipeline: A special issue from the World Health Organization Product Development for Vaccine Advisory Committee (PDVAC)

Auteur: Kevin Etter, Dr Patricia Mupeta Bobo, Ronan Terrade

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in India: A randomized, parallel group, non-inferiority trial

Auteur: Michael Egharevba, Bill Keough, Dominique Zwinkels, Mwenge Mwanamwenge

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

Auteur: World Health Organization (WHO)

Recomendaciones provisionales para usar la vacuna NVX-CoV2373 de Novavax contra la COVID-19: orientaciones provisionales, actualización del 27 de septiembre de 2022

Auteur: World Health Organization (WHO)

Recommandations provisoires pour l’utilisation du vaccin Novavax NVX-CoV2373 contre la COVID-19, mise à jour le 27 septembre 2022

Background document to the Vaccines and immunization for monkeypox interim guidance, 16 November 2022

Auteur: ThinkPlace, JSI, CHAI, VillageReach

Annexes to the Vaccines and immunization for monkeypox interim guidance: grading of evidence: evidence to recommendation tables, 16 November 2022

Auteur: Gavi, the Vaccine Alliance, World Health Organization (WHO), UNICEF, Covid-19 Vaccine Delivery Partnership

Recomendaciones provisionales para el uso de la vacuna mRNA-1273 de Moderna contra la COVID-19: orientación provisional: actualizadas el 18 de agosto de 2022

Auteur: Vietnam National Expanded Program on Immunization (NEPI), PATH

Note de synthèse: position de l’OMS concernant les vaccins contre l’hépatite A – Octobre 2022

Auteur: Vietnam National Expanded Program on Immunization (NEPI), PATH

WHO position paper on hepatitis A vaccines – October 2022

Auteur: Mick N. Mulders

Recommandations provisoires concernant l’utilisation du vaccin de Valneva (‎VLA2001)‎ contre la COVID-19 : orientations provisoires, première publication : 18 août 2022

Auteur: Mick N. Mulders

Recomendaciones provisionales sobre el uso de la vacuna BNT162b2 de Pfizer y BioNTech contra la COVID-19 en el marco de la Lista OMS de uso en emergencias: orientaciones provisionales

Auteur: Vietnam National Expanded Program on Immunization (NEPI), PATH

World Bank Covid-19 Vaccine Deployment tracker

Auteur: HECAF360

COVID-19 Vaccine Distribution: Are you ready?

Auteur: Ann Burton, Hajar Samaha, Islam Ahmed

Ways Health Departments Can Help Increase COVID-19 Vaccinations

Auteur: World Health Organization (WHO)

Global Vaccination Initiative

Auteur: Vaccine Prioritization & Platforms Team

Senegal_Rapport de la revue Inter-Action (RIA)

Auteur: JSI Research & Training Institute

AFRO learning site link

Auteur: JSI Research & Training Institute

The evolution of the Meningitis Vaccine Project

Auteur: JSI Research & Training Institute

RDC - Rapport de la revue Inter-Action (RIA)

Auteur: JSI Research & Training Institute

Guinée Bissau - Rapport de la revue Inter-Action sur la vaccination COVID-19

Auteur: JSI Research & Training Institute

Somalia - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: Albert Beckford, Jordan Lerner, Denese Palmer

Uganda - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: Lokesh Sharma, Ginisha Gupta, Bhrigu Kapuria, Snehil Kumar Singh, Sanjay Gupta, Mahesh Kumar Agarwal, Harshad Thakur

Guinea Bissau - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: World Health Organization (WHO)

South Sudan - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: Michael Nunan

DRC - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: World Health Organization (WHO)

Niger - Rapport de la revue intra-action de la vaccination contre la COVID-19 au Niger

Auteur: World Health Organization (WHO)

Mozambique - Report: COVID-19 vaccination intra-action review

Auteur: World Health Organization (WHO)

Botswana - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: World Health Organization (WHO)

Syria - Country COVID-19 Intra-Action Review (IAR) Report

Auteur: Duke University and COVID Collaborative

Good practice statement on the use of second booster doses for COVID 19 vaccines

Auteur: John Richard, Madeline Barber

Annexes to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19: grading of evidence: evidence to recommendations tables, first issued 18 August 2022

Auteur: World Bank

Background to the recommendations for use of the Valneva VLA2001 vaccine against COVID 19: background document to the WHO: interim recommendations for use of the Valneva vaccine VLA2001 against COVID-19

Auteur: USAID MOMENTUM

Interim recommendations for use of the Valneva VLA2001 vaccine against COVID 19: interim guidance, first issued 18 August 2022

Auteur: Ijeoma Agbo, Khawaja Aftab Ahmed, Nassor Mohamed

Why Gender Matters: IA2030 guide

Auteur: Dao Dinh Sang, Dang Thi Thanh Huyen

A guide for conducting a situation analysis of immunization programme performance

Auteur: UNICEF

Human-centred design for tailoring immunization programmes

Auteur: UNICEF

Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022

Auteur: Md. Jahid Hossen Shahed, Mike Frost, Muhammad Masud Parvez, Pamod Amarakoon

Behavioural and social drivers of vaccination Tools and practical guidance for achieving high uptake

Auteur: World Health Organization (WHO)

Summary of key characteristics of WHO Prequalified Rotavirus vaccines

Auteur: Rie Takesue, Dr. Abdul Jabbar, George Mwinnyaa

Considerations for Pneumococcal Conjugate Vaccine (PCV) Product Choice

Auteur: Emmanuel Bayo, Harriet Blest, Emily Nicholson

SYSVAC: Systematic Reviews on Vaccines

Auteur: Chương trình Tiêm chủng Mở rộng Quốc gia, PATH

Gavi-supported rotavirus vaccines profiles to support country decision making

Auteur: Vietnam National Expanded Program on Immunization (NEPI), PATH

WHO vaccine reaction rates information sheets

Auteur: Sangwe Clovis Nchinjoh, Mukhtar Abdi Shube, Muhammad Farid, Lisa Oot

Vaccine Detailed product profiles (DPPs) For Gavi-supported vaccines

Auteur: Dr Amy Lo Ndiaye

Product menu for vaccines supplied by UNICEF for Gavi, the Vaccine Alliance

Auteur: Dr Amy Lo Ndiaye

Highly Extensible Resource for Modeling Event-Driven Supply Chains (HERMES)

Auteur: World Bank

Service Provision Assessment (SPA) Survey

Auteur: JSI

UN OneHealth Tool, CEA country contextualization templates

Auteur: Centers for Disease Control and Prevention (CDC)

Immunization Delivery Cost Catalogue (IDCC)

Auteur: Centers for Disease Control and Prevention (CDC)

Vaccine-Preventable Diseases (including pipeline vaccines)

Auteur: Bill & Melinda Gates Foundation

List of WHO Prequalified Vaccines

Auteur: USAID

Vaccines and immunization for monkeypox: interim guidance,16 November 2022

Auteur: Rockefeller Foundation

Annexes to the recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19

Auteur: Rockefeller Foundation

Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎Convidecia™)‎ against COVID-19

Auteur: Lillian Kidane, Laura Herman, Sylvia Warren

Background document on the CanSinoBIO Ad5-nCoV-S [‎recombinant]‎ vaccine (‎ConvideciaTM)‎ against COVID-19

Auteur: Bill & Melinda Gates Foundation

UNIVAC

Auteur: Jhpiego

Vaccine Impact Modelling Consortium (VIMC)

Auteur: Johns Hopkins University

Global Health Data Exchange

Auteur: World Bank

Questions-réponses : les vaccins anti-COVID-19 et la grossesse

Auteur: Gavi, the Vaccine Alliance

Recommandations provisoires concernant l’utilisation du vaccin ChAdOx1-S [‎recombinant]‎ contre la COVID-19 (‎vaccin anti-COVID-19 d’AstraZeneca AZD1222 Vaxzevria™, SII COVISHIELD™)‎

Auteur: MoH Senegal, World Health Organization (WHO)

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé BIBP développé par China National Biotec Group (‎CNBG)‎, Sinopharm

Auteur: UNICEF, World Health Organization (WHO)

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 BBV152 COVAXIN® de Bharat Biotech

Auteur: Yacine Kretz, Dr Boston Zimba, Ghanashyam Sethy, Dr Mike Chisema, Dr. Desmond Maada Kangbai, Ida-Marie Ameda

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 inactivé, CoronaVac, développé par Sinovac

Auteur: World Health Organization (WHO)

Vaccine Vial Monitor (VVM)-based vaccine management

Auteur: WHO Regional Office for Africa (AFRO)

Utilizar parches de microarrays para administrar las vacunas contra el sarampión y la rubéola (16ª Conferencia TechNet)

Auteur: Maldives Government

Como cambiar el tamaño de los frascos puede mejorar sus servicios de inmunización (16ª Conferencia TechNet)

Auteur: RDC Government

Des patchs à micro-aiguilles pour administrer les vaccins contre la rougeole et la rubéole ? (16ème Conférence TechNet)

Auteur: USAID MOMENTUM, COVID GAP

Comment le changement de taille des flacons peut améliorer vos services de vaccination (16ème Conférence TechNet)

Auteur: MM Global Health Consulting (MMGH)

How, where and when are we going to use microarray patches to deliver measles and rubella vaccines? (16th TechNet Conference)

Auteur: Niger Government

How changing vial size can improve your immunization services (16th TechNet Conference)

Auteur: Carrie Nielsen, Enrique Paz, June Ojukwu, Sara Al-Dahir

Findings from a healthcare worker evaluation of the COVID19 vaccine label

Auteur: COVID GAP, USAID MOMENTUM, World Health Organization (WHO)

Recommandations provisoires pour l’utilisation du vaccin Moderna (‎mRNA-1273)‎ contre la COVID-19 : orientations provisoires, mise à jour le 18 août 2022

Auteur: World Health Organization (WHO), UNICEF

Note de synthèse: position de l’OMS sur les vaccins contre la dengue – mai 2024

Auteur: World Health Organization (WHO), Banque Mondiale

Note de synthèse: position de l’OMS à propos des vaccins contre l’encéphalite japonaise – février 2015

Auteur: World Health Organization (WHO)

Comment lire une pastille de contrôle des vaccins (PCV)?

Auteur: World Health Organization (WHO)

Déclaration de politique générale de l'OMS : révision de la politique relative aux flacons multidoses : manipulation des flacons de vaccin multidoses entamés, Révision 2014

Auteur: World Bank, World Health Organization (WHO)

Note de synthèse: position de l’OMS à propos du vaccin antipaludique – mai 2024

Auteur: MoH South Sudan

Malaria vaccine: WHO position paper

Auteur: World Health Organization (WHO)

Comment appliquer la politique d'utilisation des flacons multidoses

Auteur: World Health Organization (WHO)

Pastilles de contrôle des vaccins

Auteur: World Health Organization (WHO)

Synthèse technique des données actuelles publiées sur la vaccination à dose unique contre le PVH

Auteur: World Health Organization (WHO)

Résumé général des données actuelles publiées sur la vaccination à dose unique contre le PVH

Auteur: World Health Organization (WHO)

Vaccin ChAdOx1-S [recombinant] contre la COVID-19

Auteur: World Health Organization (WHO), UNICEF

Vaccin contre la COVID-19 (cellule Vero), inactivé, CoronaVac

Auteur: UNICEF

Recommandations provisoires pour l’utilisation du vaccin anti-COVID-19 Pfizer-BioNTech, BNT162b2, en vertu du protocole OMS d’autorisation d’utilisation d’urgence

Auteur: UNICEF, World Health Organization (WHO)

Background document on the Novavax (NVX-CoV2373) vaccine against COVID-19

Auteur: Johanna Fihman

COVAXIN® (BBV152) – Inactivated, COVID-19 vaccine

Auteur: World Health Organization (WHO)

Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19 - update 27 September 2022

Auteur: World Health Organization (WHO)

Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19 - update 27 September 2022

Auteur: MM Global Health Consulting (MMGH)

Interim recommendations for heterologous COVID-19 vaccine schedules

Auteur: Lokesh Sharma, Snehil K Singh, Ranjit Dhiman

Annexes to the interim recommendations for use of the Janssen Ad26.COV2.S vaccine

Auteur: Ghanashyam Sethy, Lokesh Sharma, Tedla Damte, Antoinette Eleonore Ba, Patrick Omar Nicks

Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19, updated 18 August 2022

Auteur: UNICEF

Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19, updated 18 August 2022

Auteur: Gavi, the Vaccine Alliance

COMIRNATY® (Tozinameran), vaccin à ARNm contre la COVID-19 (nucléoside modifié)

Auteur: Chizoba Wonodi

Vaccin Janssen contre la COVID-19(Ad26.COV2-S [recombinant])

Auteur: UNICEF, World Health Organization (WHO)

Stakeholder preferences for a new rotavirus vaccine candidate

Auteur: Breakthrough ACTION

Impact and cost-effectiveness of an injectable rotavirus vaccine candidate compared to oral rotavirus vaccines

Auteur: World Health Organization (WHO)

A compelling public health value proposition for injectable next-generation rotavirus vaccines

Auteur: World Health Organization (WHO)

Global Market Study : Malaria - 2021

Auteur: World Health Organization (WHO)

Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 - update 15 March 2022

Auteur: World Health Organization (WHO)

Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19 - update 15 March 2022

Auteur: World Health Organization (WHO)

Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine

Auteur: IA2030 Partnership

Group B Streptococcus vaccine: full value of vaccine assessment. Financial analysis

Auteur: IA2030 Partnership

Full Value of Vaccine Assessment: Group B Streptococcus Vaccine - Policy and Implementation Issues

Auteur: IA2030 Partnership

Full Value of Vaccine Assessment: Group B Streptococcus Vaccine Executive Summary

Auteur: IA2030 Partnership

Group B Streptococcus Vaccine: full value vaccine assessment

Auteur: UNICEF

Background document on the inactivated vaccine Sinovac-CoronaVac against COVID-19

Auteur: UNICEF

Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables - update 15 March 2022

Auteur: World Health Organization (WHO)

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac - update 15 March 2022

Auteur: World Health Organization (WHO)

CDC Resource page on Janssen COVID-19 Vaccine (Johnson & Johnson)

Auteur: World Health Organization (WHO)

CDC Resource page on Moderna COVID-19 Vaccine

Auteur: World Health Organization (WHO)

Pfizer-BioNTech COVID-19 Vaccine and low dead-volume (LDV) syringes and-or needles

Auteur: World Health Organization (WHO)

COVID-19 Vaccine Explainer - COVID-19 Vaccine (Vero Cell), Inactivated, CoronaVac®

Auteur: World Health Organization (WHO)

Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) - update 15 March 2022

Auteur: World Health Organization (WHO)

Covid-19 Vaccine Job Aid: Why are there extra doses of vaccine in the vaccine vial?

Auteur: World Health Organization (WHO)

COVID-19 Vaccine Explainer - COVID-19 Vaccine (Vero Cell), Inactivated (Sinopharm)

Auteur: World Health Organization (WHO)

Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions

Auteur: World Health Organization (WHO)

Findings from a healthcare worker evaluation of the COVID19 vaccine label

Auteur: World Health Organization (WHO)

Background document on the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm

Auteur: World Health Organization (WHO)

Annexes to the interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm - update 15 March 2022

Auteur: Odile Leroy, Michael Mowatt

Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm - update 15 March 2022

Auteur: Helen Rees

To optimize COVID-19 vaccine rollout, listen to health workers

Auteur: Jean-Marie Okwo-Bele

Living Labs Initiative Overview

Auteur: K. Neuzil

COVID-19 Vaccine Explainer - COVID-19 Vaccine Janssen (Ad26.COV2-S [recombinant]) - UPDATED JULY 2022

Auteur: David Salisbury

Sample size calculator for evaluation of COVID-19 vaccine effectiveness

Auteur: Trevor Mundel

Evaluation of COVID-19 vaccine effectiveness

Auteur: Tim Evans, Margaret Chan

COVID-19 Vaccine Label: User Evaluation

Auteur: GVIRF Secretariat

A general summary of current published evidence for single-dose HPV vaccination

Auteur: Saad Omer

Technical synthesis of the current published evidence for single-dose HPV vaccination

Auteur: Bernadette Abela-Ridder

COVID-19 Vaccine Explainer - COVID-19 Vaccine Moderna (nucleoside modified), (mRNA-1273)

Auteur: Judith Kallenberg

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19, updated 18 August 2022

Auteur: Melissa Malhame

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) - update 15 March 2022

Auteur: Peter Dull

Interim recommendations for the use of the Janssen Ad26.COV2.S (‎COVID-19)‎ vaccine: interim guidance

Auteur: Michel De Wilde

COVID-19 Vaccine Explainer - AstraZeneca ChAdOx1-S/nCoV-19 [recombinant]

Auteur: James Fleckenstein

The COVID-19 candidate vaccine landscape and tracker

Auteur: Jane Deng

Background document on the AZD1222 vaccine against COVID-19 developed by Oxford University and AstraZeneca

Auteur: María Gloria Domínguez-Bello

Vaccine Dose Per Container: Deciding What's Right For Your Immunization Program

Auteur: Willem Hanekom

Implementing 5-dose Measles-Rubella Vaccine Vials in Zambia Research Findings

Auteur: Bali Pulendran

COVID-19 Vaccine Explainer - COMIRNATY® (Tozinameran)

Auteur: Ingileif Jonsdottir

Review of the current, public evidence on single-dose HPV vaccination

Auteur: Marion Gruber

Covid-19 vaccines: safety surveillance manual

Auteur: Teeranart Jivapaisarnpong

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing, updated 18 August 2022

Auteur: Norman W. Baylor

Monitoring the cold chain: What Temperatures Should Vaccines Be?

Auteur: Debra Kristensen

Administering: Using the Multi-Dose Vial Policy

Auteur: Olivier Ronveaux

WHO Policy Statement: Multi-dose Vial Policy (MDVP)

Auteur: Darin Zehrung

How to read a VVM - Infographic

Auteur: Margaret Gyapong

Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability

Auteur: Cara Bess Janusz

[DUPLICATE] How changing vial size can improve your immunization services (16th TechNet Conference)

Auteur: Fadima YAYA BOCOUM

How, where and when are we going to use microarray patches to deliver measles and rubella vaccines? (16th TechNet Conference)

Auteur: John Clemens

Pneumococcal Vaccine: Handling the change in product manufacturer and presentation

Auteur: William Moss

Pneumococcal Conjugate Vaccine (PCV) 4-dose vial presentations - Frequently Asked Questions (FAQs)

Auteur: Thomas Cherian

Characteristics of different presentations of Pneumococcal Conjugate Vaccines

Auteur: D. Briggs

Japanese Encephalitis Vaccines: WHO position paper

Auteur: Farrokh Modabber

Introducing 5-dose Measles-Rubella Vaccine Vials in Zambia: Research Findings

Auteur: Florian Schödel

The Effects of Dose Per Container Change in Zambia

Auteur: Claudio Lanata

Vaccine Vial Monitor (VVM)-based vaccine management

Auteur: Vasee Moorthy

Review of the current published evidence for single-dose HPV vaccination

Auteur: David Spiro

Webinar: Integrating Drones into Immunization Supply Chains

Auteur: Martin Friede

freeze free type vaccine carrier

Auteur: Claire-Anne Siegrist

[DUPLICATE] Vaccine Dose Per Container: Deciding What's Right for Your Immunization Program

Auteur: Keith Klugman

Mumps vaccines: WHO position paper

Auteur: Alba Maria Ropero-Alvarez

Introducing the Measles and Measles-Rubella (MR) Vaccine Five-dose vial Presentations Facts Sheet

Auteur: M. Carolina Danovaro-Holliday

Immunization Dose Per Container: Decision Support Resource

Auteur: Kathleen Neuzil

Measles and Measles-Rubella (MR) Vaccine Five-dose vial Presentations Facts Sheet

Auteur: Mary K. Estes

Overview: Vaccine Preventable Diseases Surveillance Standards

Auteur: Umesh Parashar

Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data

Auteur: Kathleen Neuzil

Utilisation du MenAfriVac™ (vaccin contre la méningite A) en chaîne à température contrôlée (CTC) pendant les campagnes - Guide d'adaptation et guide du formateur

Auteur: Marion Gruber

Utilisation du MenAfriVac™ (vaccin contre la méningite A) en chaîne à température contrôlée (CTC) pendant les campagnes - Module de formation pour l'organisation de séances de vaccination

Auteur: Peter Smith

Utilisation du MenAfriVac™ (vaccin contre la méningite A) en chaîne à température contrôlée (CTC) pendant les campagnes - Guide à l'intention des décideurs et des administrateurs des programmes de vaccination

Auteur: Peter Smith

Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia

Auteur: Ashley Birkett

The future control of rotavirus disease: Can live oral vaccines alone solve the rotavirus problem?

Auteur: Uli Fruth

Typhoid vaccines: WHO position paper – March 2018

Auteur: Tom Evans

Impact and effectiveness of meningococcal vaccines: a review

Auteur: José Esparza

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array

Auteur: Wayne Koff

Urgent challenges in implementing live attenuated influenza vaccine

Auteur: Trevor Mundel

Implementation of hepatitis B birth dose vaccination – worldwide, 2016

Auteur: T. Evans, World Bank

Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia

Auteur: Margaret Chan

Immunogenicity of fractional-dose vaccine during a Yellow Fever outbreak — Preliminary report

Auteur: José Esparza

Cost of goods sold and total cost of delivery for oral and parenteral vaccine packaging formats

Auteur: Joachim Hombach

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Auteur: Ingileif Jonsdottir

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

Auteur: Norman Baylor, Helen Rees

A field guide to qualitative research for new vaccine introduction

Auteur: R. Lagos, M. Gottlieb

The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia

Auteur: A. A. Adeyemo

A thermostable messenger RNA based vaccine against rabies

Auteur: A. A. Adeyemo

The influence of probiotics on vaccine responses – A systematic review

Auteur: David Spiro

Cost-effectiveness of dengue vaccination in ten endemic countries

Auteur: Jan Grevendonk

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

Auteur: Abigail Shefer

Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination

Auteur: Elicah Kandinda Kamiji

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report

Auteur: Imran Mirza

Gonorrhoea vaccines: a step in the right direction

Auteur: Rudi Eggers

Placebo use in vaccine trials: Recommendations of a WHO expert panel

Auteur: Rebecca Fields

A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infant

Auteur: Nelson Michael

Serum Institute’s vaccine demonstrates significant efficacy against severe rotavirus gastroenteritis

Auteur: Dicky Akanmori

Intradermal Administration of Fractional Doses of Inactivated Poliovirus Vaccine: A Dose-Sparing Option for Polio Immunization

Auteur: William Wekwete

A freeze-stable formulation for DTwP and DTaP vaccines

Auteur: Klaus Cichutek

Target Product Profile: Measles-Rubella Microarray Patch

Auteur: Jordi Rello

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial

Auteur: Magnus Unemo

An updated methodology to review developing-country vaccine manufacturer viability

Auteur: Olaf Schneewind

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls

Auteur: Bruce Gellin

Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial

Auteur: Martin Friede

Vaccine Design

Auteur: A. A. Adeyemo

There's a New Effective Vaccine to Combat Rotavirus

Auteur: Mercy Mvundura

Vial usage, device dead space, vaccine wastage, and dose accuracy of intradermal delivery devices for inactivated poliovirus vaccine (IPV)

Auteur: Darin Zehrung

Intradermal vaccination using the novel microneedle device MicronJet600: Past, present, and future.

Auteur: Tina Lorenson

Usability evaluation of intradermal adapters (IDA)

Auteur: Tina Lorenson

Rotavirus Vaccine Technical Briefings (January 2017)

Auteur: Peter Smith

PCV Evidence Base

Auteur: Nicola Christofides and Janine Simon-Meyer

PCV Technical Briefings

Auteur: Ann Lindstrand

Gap Analysis of Rotavirus Vaccine Impact Evaluations in Settings of Routine Use

Auteur: Susan Goldstein

Gap Analyses of PCV Vaccine Impact Evaluations in Settings of Routine Use

Auteur: Robb Butler

VIEW-hub Report

Auteur: Tsepo Tsekoa

Development of improved vaccine cell lines against rotavirus

Auteur: Wayne Koff

Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: A randomized controlled trial in Cuba

Auteur: Filip Dubovsky

Microneedle patches for vaccination in developing countries

Auteur: Martin Friede

An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine

Auteur: Neil King

Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch

Auteur: Bill Schief

Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque

Auteur: Felix Rey

Measles vaccination using a microneedle patch

Auteur: Rino Rappuoli

Cutaneous vaccination – Protective immunization is just a skin-deep step away

Auteur: Stephen Hadley

Effect of jet injection on infectivity of measles, mumps, and rubella vaccine in a bench model

Auteur: Bruce Innis

Randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe

Auteur: Erin Sparrow

Stability of live attenuated rotavirus vaccine with selected preservatives and primary containers

Auteur: Barney Graham

Presentation matters: Buffers, packaging, and delivery devices for new, oral enteric vaccines for infants

Auteur: Suphot Wattanaphansak

Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children

Auteur: Edgar Brun

Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy

Auteur: Dennis Dixon

Opportunities and challenges in delivering influenza vaccine by microneedle patch

Auteur: Jean Lang

WHO Microarray Patch (MAP) Product Development Workshop

Auteur: Maria Elena Bottazzi

The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different Temperatures

Auteur: Andrea Cox

First-in-human safety and immunogenicity investigations of 3 adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster to adolescents with a history of IPV vaccination

Auteur: Ruth Karron

Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis

Auteur: David Kaslow

Implementing an ebola vaccine study - Sierra Leone

Auteur: Raymond Hutubessy

Improving immunization approaches to cholera

Auteur: Hartono Gunardi

Which JE vaccine should my country use? (module 3)

Auteur: Helen Rees

Preferred Product Characteristics: Measles-Rubella Microarray Patch

Auteur: A. A. Adeyemo

Safety and immunogenicity of M-M-RII (combination measles-mumps-rubella vaccine) in clinical trials of healthy children conducted between 1988 and 2009.

Auteur: Stephen Thomas, Lucky Slamet

Portable, on-demand biomolecular manufacturing

Auteur: David Kaslow

Questions and answers on the withdrawal of the CPMP Note for guidance on preclinical pharmacological and toxicological testing of vaccines

Auteur: Annie Mo

Seven-year efficacy of RTS,S/AS01 malaria vaccine among young African children

Auteur: Andrew Steer

June 2016 VIEW-hub Report on Global Introduction and Implementation

Auteur: James Goodson

Thermostability of vaccines

Auteur: Narendra K Arora

An HIV vaccine: Mapping uncharted territory

Auteur: Kimberly Thompson

Multicriteria decision analysis and core values for enhancing vaccine-related decision-making

Auteur: Peter Strebel

Rotavirus serum IgA immune response in children receiving rotarix(R) co-administered with bOPV or IPV

Auteur: A. A. Adeyemo

Long-term protective effects of hepatitis A vaccines. A systematic review

Auteur: Delese Mimi Darko

Plant-made oral vaccines against human infectious diseases—Are we there yet?

Auteur: Lucille Blumberg

Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies

Auteur: David Wook

Antibody secreting cell responses following vaccination with bivalent oral cholera vaccine among Haitian adults

Auteur: Norman Baylor, Helen Rees

Biological challenges to effective vaccines in the developing world

Auteur: Amie Batson

Safety and immunogenicity of novel adenovirus type 26– and modified vaccinia Ankara–vectored ebola Vaccines

Auteur: A. Batson

Progress in introduction of pneumococcal conjugate vaccine — worldwide, 2000–2012

Auteur: Walter Jaoko

Identifying optimal vaccination strategies for serogroup A Neisseria Meningitidis Conjugate vaccine in the African meningitis belt

Auteur: Salim Abdullah

13-Valent pneumo vaccine (PCV13) in children partially immunized with 7-valent pneumo vaccine

Auteur: Katherine L. O'Brien

Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh

Auteur: Kathleen Neuzil

ffectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case–control study

Auteur: Katherine L. O'Brien

Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations.

Auteur: Mahamadou Thera

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Auteur: Eusebio Macete

Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by tdap brand

Auteur: Lewis Schrager

Cholera vaccine: New preventive tool for endemic countries

Auteur: Nelson Michael

Malaria vaccine: WHO position paper – May 2024

Auteur: Glenda Gray

A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus

Auteur: William Ampofo

Clinical experience with the meningococcal B vaccine, Bexsero®: Prospects for reducing the burden of meningococcal serogroup B disease

Auteur: GVIRF Secretariat

Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction

Auteur: Odile Leroy

Smallpox vaccines: targets of protective immunity

Auteur: Jennifer Gordon

Analysis of safety data in children after receiving two doses of ProQuad® (MMRV)

Auteur: Punee Pitisuttithum

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models

Auteur: John S. Tam

Microneedle technology for immunisation: Perception, acceptability and suitability for paediatric use.

Auteur: Martin Friede

Varicella and herpes zoster vaccines: WHO position paper, June 2014 - Recommendations.

Auteur: Christian Ockenhouse

Comparative effects of carrier proteins on vaccine-induced immune response

Auteur: Lisa Wagar

Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo

Auteur: Annie Mo

Vaccine design reaches the atomic level

Auteur: Keith Klugman

Report of the Immunization and Vaccines related Implementation Research (IVIR), Advisory Committee Meeting

Auteur: Lisa Menning

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans

Auteur: Lisa Menning

Vaccine production, distribution, access, and uptake

Auteur: Lisa Menning

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update

Auteur: Lisa Menning

Parental Attitudes and Beliefs Regarding the Nine-Valent Human Papillomavirus Vaccine.

Auteur: Lisa Menning

Combination Measles-Mumps-Rubella-Varicella Vaccine in Healthy Children: A Systematic Review and Meta-analysis of Immunogenicity and Safety.

Auteur: Lisa Menning

Intellectual property rights and challenges for development of affordable human papillomavirus, rotavirus and pneumococcal vaccines: Patent landscaping and perspectives of developing country vaccine manufacturers

Auteur: Yohannes Lakew, Adriana Alminana, Amare Bayeh

Structural damages in adsorbed vaccines affected by freezing

Auteur: World Health Organization (WHO)

Stabilization of vaccines and antibiotics in silk and eliminating the cold chain

Auteur: Souleymane Kone

From empiricism to rational design: a personal perspective of the evolution of vaccine development

Auteur: Nora Lucia Rodriguez, Pablo Llopis, Leonardo Pealta, Michelle Seidel

Safety and immunogenicity of a primary series of Sabin-IPV with and without aluminum hydroxide in infants

Auteur: Anita Sands, Edouard Munyangaju, Enric Jané, Max Kabalisa

Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles

Auteur: Anita Sands, Max Kabalisa, Lisa Hedman, Enric Jané, Edouard Munyangaju

Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review

Auteur: Lisa Hedman, Max Kabalisa, Anita Sands, Edouard Munyangaju, Enric Jané

Duration of vaccine efficacy against malaria: 5th year of follow-up in children vaccinated with RTS,S/AS02 in Mozambique

Auteur: Stephanie Shendale, Carla Toko, Sofia de Almeida

Tuberculosis vaccines – rethinking the current paradigm

Auteur: Stephanie Shendale, Sofia de Almeida, Carla Toko

Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine

Auteur: Carla Toko, Sofia de Almeida, Stephanie Shendale

Human papillomavirus vaccination coverage among adolescents, 2007–2013, and postlicensure vaccine safety monitoring, 2006–2014 — United States

Auteur: Claude Mangobo, Mojtaba Haghgou, Mohammad Shadan, Solo Kone, Maricel Castro

Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial

Auteur: Mojtaba Haghgou, Claude Mangobo, Mohammad Shadan, Solo Kone, Maricel Castro

Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study

Auteur: Souleymane Kone

What can rotavirus vaccines teach us about rotavirus?

Auteur: Michelle Seidel, Karan Sagar

Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa

Auteur: Dr.Ngembus Albjerky, Dr. Mbianke Livancliff, Gloria Lihemo, Dr. Edwin Mung'ong'o, Dr. Mwendwa Eunice Mwenesi, Dr. Leonard Ndamgoba

Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality

Auteur: Zabihullah Kamran, Baboucarr Boye, Godiskine Attemenego, Maricel Castro

Dengue vaccines: Dawning at last?

Auteur: Godiskine Attemenego, Baboucarr Boye, Zabihullah Kamran, Maricel Castro

Development of a novel malarial vaccine design – A hypothetical approach

Auteur: Godiskine Attemenego, Zabihullah Kamran, Baboucarr Boye, Maricel Castro

Is Canada patent deal obstructing Ebola vaccine development?

Auteur: Leonardo Pealta, Michelle Seidel, Nora Lucia Rodriguez, Pablo Llopis

HPV vaccination: for women of all ages?

Auteur: Pablo Llopis, Leonardo Pealta, Michelle Seidel, Nora Lucia Rodriguez

Antibody persistence 5 years after vaccination at 2 to 10 years of age with Quadrivalent MenACWY-CRM conjugate vaccine, and responses to a booster vaccination

Auteur: Michelle Seidel, Leonardo Pealta, Pablo Llopis, Nora Lucia Rodriguez

Evidence base for new vaccine introduction in Latin America and the Caribbean

Auteur: World Health Organization (WHO)

A systematic review of anti-rotavirus serum IgA antibody titer as a potential correlate of rotavirus vaccine efficacy

Auteur: World Health Organization (WHO)

The state-of-the-art of approved and under-development cholera vaccines

Auteur: World Health Organization (WHO)

Ebola and Marburg vaccines for Africa: one step closer

Auteur: Alexis Satoulou-Maleyo, Johanna Fihman

New HPV vaccine provides wider protection

Auteur: World Health Organization (WHO)

Hepatitis E vaccine effective for 4.5 years

Auteur: World Health Organization (WHO)

Workshop report: Malaria vaccine development in Europe–preparing for the future

Auteur: Solo Kone, Claude Mangobo, Mojtaba Haghgou, Maricel Castro, Mohammad Shadan

WHO guidance note: Vaccine diluents, revision 2015

Auteur: World Health Organization (WHO)

EV71 vaccine: protection from a previously neglected disease

Auteur: World Health Organization (WHO)

Comparing safety & immunogenicity of TB vaccine MVA85A through intramuscular and intradermal routes

Auteur: Gavi, the Vaccine Alliance

Alternative delivery of a thermostable inactivated polio vaccine

Auteur: Gavi, the Vaccine Alliance

Towards ambient temperature-stable vaccines

Auteur: World Health Organization (WHO)

Rabies vaccine preserved by vaporization is thermostable and immunogenic

Auteur: World Health Organization (WHO)

The economic value of a visceral leishmaniasis vaccine in Bihar state, India

Auteur: World Health Organization (WHO)

Prevention of pneumococcal infection with vaccines

Auteur: World Health Organization (WHO)

The access to medicine index 2014

Auteur: World Health Organization (WHO)

Accelerating vaccine development and deployment

Auteur: World Health Organization (WHO)

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

Auteur: UNICEF

Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life

Auteur: World Health Organization (WHO)

Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process

Auteur: World Health Organization (WHO)

Japanese Encephalitis Vaccines: WHO position paper, February 2015 - Recommendations

Auteur: Robert Koch Institute

New developments in dry powder pulmonary vaccine delivery

Auteur: Gavi, the Vaccine Alliance

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

Auteur: World Health Organization (WHO)

Research agenda for malaria eradication: Vaccines

Auteur: Gavi, the Vaccine Alliance

Dengue vaccines regulatory pathways

Auteur: UNICEF

The use of propolis as vaccine's adjuvant

Auteur: Johns Hopkins University

Immunogenicity of bivalent types 1 and 3 oral poliovirus vaccine: a randomised, double-blind, controlled trial

Auteur: DHS

Is vaccine the magic bullet for malaria elimination? A reality check

Auteur: UN InterAgency WG on Costing

Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine

Auteur: Souleymane Kone, Michelle Seidel, Karan Sagar

The twenty-year story of a plant-based vaccine against Hep B: stagnation or promising prospect?

Auteur: Michelle Seidel, Karan Sagar

WHO Working Group on technical specifications for manufacture and evaluation of dengue vaccines

Auteur: Epiconcept

Low Cost Tuberculosis vaccine antigens in capsules: expression in chloroplasts

Auteur: Chương trình Tiêm chủng Mở rộng Quốc gia, PATH

Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial

Auteur: Vietnam National Expanded Program on Immunization (NEPI), PATH

Assessment of the RTS,S/AS01 malaria vaccine

Auteur: World Health Organization (WHO)

HPV vaccination—reaping the rewards of the appliance of science

Auteur: World Health Organization (WHO)

A polymer/oil based nanovaccine as a single-dose immunization approach

Auteur: Adama Sawadogo, Hamed Idrissa Traore, Modibo Dicko

Trend of human rabies prophylaxis in developing countries: Toward optimal rabies immunization

Auteur: Adama Sawadogo, Hamed Idrissa Traore, Modibo Dicko

The expanding vaccine development pipeline, 1995–2008

Auteur: Paul Colrain

WHO policy development processes for a new vaccine: case study of malaria vaccines

Auteur: Paul Colrain

Malaria vaccine research and development: the role of the WHO MALVAC committee

Auteur: World Health Organization (WHO)

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia

Auteur: Lidia Kuznetsova, Giorgio Cortassa, Antoni Trilla

Vaccine R&D: Past performance is no guide to the future

Auteur: The Balanzan Institute, UNICEF, World Health Organization (WHO)

Vaccine Presentation Assessment Tool: Analytical approach and user guide

Auteur: OMS - Bureau régional pour l'Afrique

Estimating the cost of cholera-vaccine delivery from the societal point of view: A case of introduction of cholera vaccine in Bangladesh

Auteur: WHO Regional Office for Africa (AFRO)

The value of childhood combination vaccines: From beliefs to evidence

Auteur: Modibo Dicko, Hamed Idrissa Traore

1885, the first rabies vaccination in humans

Auteur: John Dadzie, Olamide Folorunso, Yoms Ishaku

Profiling the host response to malaria vaccination and malaria challenge

Auteur: Yoms Ishaku, John Dadzie, Olamide Folorunso

Brazilian meningococcal C conjugate vaccine: Scaling up studies

Auteur: World Health Organization (WHO)

A cluster randomized non-inferiority field trial on the immunogenicity and safety of tetanus toxoid vaccine kept in controlled temperature chain compared to cold chain

Auteur: World Health Organization (WHO)

Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns : training module for organizing immunization sessions

Auteur: UNICEF

Use of MenAfriVac™ (meningitis A vaccine) in a controlled temperature chain (CTC) during campaigns: guidance for immunization programme decision-makers and managers

Auteur: Thinkwell

The impact of heptavalent PCV on the incidence of childhood community-acquired pneumonia & bacteriologically confirmed pneumococcal pneumonia in Japan

Auteur: WHO Regional Office for the Americas (PAHO)

Designing vaccines for developing-country populations: ideal attributes, delivery devices, and presentation formats

Auteur: World Health Organization (WHO)

Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children

Auteur: World Health Organization (WHO)

Imperfect vaccination can enhance the transmission of highly virulent pathogens

Efficacy and long-term safety of a dengue vaccine in regions of endemic disease

Auteur: Munjal Kothari

Invasive pneumococcal disease following the introduction of 13-valent conjugate vaccine in children in New York city from 2007 to 2012

Auteur: UNICEF

Page 1/98

Parcourir le Centre de Connaissances

Du blog

New post test

Jeudi 8 Août 2024 - par Test user

Launch of the new immunizationeconomics.org website including resource library

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

PAHO launches new web pages to help countries increase vaccine demand

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

PAHO publishes March issue of immunization newsletter

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

PAHO publishes field guide on maternal and neonatal tetanus elimination

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

PAHO launches online dashboard for routine immunization in the Americas

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

National Immunization Strategy kick-off and training in Indonesia

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

Nigeria introduces HPV to protect 7.7 million girls in the country

Jeudi 13 Juin 2024 - par Global Immunization Newsletter

PAHO - innovative country experiences to promote vaccination

Mercredi 15 Mai 2024 - par Global Immunization Newsletter

The socio-economic value of adult immunization programmes

Mercredi 15 Mai 2024 - par Global Immunization Newsletter

Global Polio Eradication Initiative (GPEI) Integration Fact Sheet

Mercredi 15 Mai 2024 - par Global Immunization Newsletter

2023 Annual Expanded Program on Immunization (EPI) Managers Meeting for West Africa

Mardi 14 Mai 2024 - par Global Immunization Newsletter

South-East Asia Expert Panel for verification of Hepatitis B Control

Mardi 14 Mai 2024 - par Global Immunization Newsletter

Joint national/international EPI and vaccine preventable disease surveillance review in Bhutan

Mardi 14 Mai 2024 - par Global Immunization Newsletter

Strengthening the management of Immunization Data in the Americas

Mardi 14 Mai 2024 - par Global Immunization Newsletter

WHO WPRO World Immunization Week 2024 / EPI @50th

Lundi 13 Mai 2024 - par Global Immunization Newsletter

Regional workshop to strengthen VPD surveillance and outbreak response in SEARO

Lundi 13 Mai 2024 - par Global Immunization Newsletter

Vaccination Week 2024 in the Americas

Lundi 13 Mai 2024 - par Global Immunization Newsletter

WORLD HEALTH ORGANIZATION_WER No. 18, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 18, 2024

Vendredi 3 Mai 2024 - par Dan Brigden

Third Annual Meeting of the RCV of Measles, Rubella and CRS

Mardi 2 Avril 2024 - par Global Immunization Newsletter

10th Product Development for Vaccine Research Committee (PDVAC) Meeting

Mardi 2 Avril 2024 - par Global Immunization Newsletter

Webinar Application of a Life Course Approach to National Immunization Programs

Mardi 2 Avril 2024 - par Global Immunization Newsletter

Workshop to strengthen immunization programs in the Americas, Lima, Peru

Mardi 2 Avril 2024 - par Global Immunization Newsletter

WORLD HEALTH ORGANIZATION_WER No. 13, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 13, 2024

Vendredi 29 Mars 2024 - par Dan Brigden

WORLD HEALTH ORGANIZATION_WER No. 12, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 12, 2024

Vendredi 22 Mars 2024 - par Dan Brigden

WORLD HEALTH ORGANIZATION_WER No. 11, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 11, 2024

Vendredi 15 Mars 2024 - par Dan Brigden

Technical cooperation on the immunization information and data quality system in Peru

Vendredi 8 Mars 2024 - par Global Immunization Newsletter

Tools for monitoring integrated public health interventions, vaccination and deworming for geohelminthiasis

Vendredi 8 Mars 2024 - par Global Immunization Newsletter

Strengthening the Management of Immunization Data in the Americas

Vendredi 8 Mars 2024 - par Global Immunization Newsletter

Moving the Needle: January 2024 news from PATH on vaccine development

Mercredi 24 Janvier 2024 - par Moderator

WORLD HEALTH ORGANIZATION_WER No. 03, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 03, 2024

Lundi 22 Janvier 2024 - par Dan Brigden

Call for resources: ThinkWell is inviting researchers to submit evidence on the cost of delivering immunization services

Lundi 22 Janvier 2024 - par Global Immunization Newsletter

New evidence on the cost of the delivery of COVID-19 vaccines in Mozambique and the Philippines

Lundi 22 Janvier 2024 - par Global Immunization Newsletter

Deep dive exercise for improving the coverage of Pneumococcal Conjugate Vaccine in Maharashtra, India

Lundi 22 Janvier 2024 - par Global Immunization Newsletter

WORLD HEALTH ORGANIZATION_WER No. 01/02, 2024 / ORGANISATION MONDIALE DE LA SANTE_REH No. 01/02, 2024

Vendredi 12 Janvier 2024 - par Dan Brigden

Health professionals share Teach to Reach 9 learning

Lundi 18 Décembre 2023 - par Global Immunization Newsletter

How to achieve high uptake of malaria vaccines? New practical guides published for planning and implementation.

Lundi 18 Décembre 2023 - par Global Immunization Newsletter

Global Meeting on Monitoring Immunization in the Context of IA2030

Lundi 18 Décembre 2023 - par Global Immunization Newsletter

Enhancing capacity for response and microplanning through workshops in Guatemala

Lundi 18 Décembre 2023 - par Global Immunization Newsletter

Building Better Immunity: a life course approach to healthy longevity

Lundi 13 Novembre 2023 - par Global Immunization Newsletter

What did it cost to deliver COVID-19 vaccines in Côte d’Ivoire and Vietnam?

Lundi 13 Novembre 2023 - par Global Immunization Newsletter

17th TechNet Conference - Immunization Programs That Leave No One Behind

Lundi 13 Novembre 2023 - par Global Immunization Newsletter

Amidst challenges, Malawi delivers for the children

Lundi 13 Novembre 2023 - par Global Immunization Newsletter

Page 1/9

Messages de forum récents

HLN Transitions its Award Winning ICE Open Source Immunization Forecaster to v2 with Technical Updates

Mercredi 21 Août 2024 - par Lux Phatak

Inquiry on Hexavalent Vaccine Data (HEXASIIL)

Mardi 23 Juillet 2024 - par Mohamad Al Hamad

HLN supports updates to several vaccine groups in its Award Winning ICE Open Source Immunization Forecaster

Vendredi 21 Juin 2024 - par Lux Phatak

Seeking Project Input- Records Understanding

Lundi 8 Avril 2024 - par Andie Lyons

WHO SAGE CALL FOR APPLICATION IS OPEN

Vendredi 29 Mars 2024 - par Jaya Lamichhane (WHO ID)

HLN Supports Updated COVID-19 Recommendations in its Award Winning ICE Open Source Immunization Forecaster

Lundi 4 Mars 2024 - par Lux Phatak

Invitation to participate in prioritization of HPV vaccine implementation research questions survey (EN FR ES RUS).

Mercredi 28 Février 2024 - par Paul Bloem

Dose Decommissioning old and obsolete cold chain equipment worth advocacy/attention?

Vendredi 5 Janvier 2024 - par Tariku Berhanu Desalegn

HLN Releases Updates to Pneumococcal Vaccine Group in its Award Winning ICE Open Source Immunization Forecaster

Lundi 6 Novembre 2023 - par Lux Phatak

MR Vaccine

Lundi 6 Novembre 2023 - par Dr. Chandralal Mongar

Mercredi 20 Septembre 2023 - par The mSupply Foundation

Seeking Feedback

Jeudi 6 Août 2020 - par Nicholas Murphy

World Immunization Week webinar series recordings available online

Mercredi 27 Mai 2020 - par Alex

2019 Pneumonia & Diarrhea Progress Report Card

Mardi 12 Novembre 2019 - par Molly Sauer

New Topic Page: Dose Per Container (DPC)

Mercredi 19 Juin 2019 - par Kelly McDonald

IVAC VIMS Report on Global Vaccine Introduction - January 2015 (Now with IPV)

Vendredi 20 Février 2015 - par Thuy-Linh Nguyen

IVAC VIMS Report on Global Vaccine Introduction - September 2014

Mardi 18 Novembre 2014 - par Thuy-Linh Nguyen

Vacancy: Advocacy & communications officer, International Vaccine Access Center (IVAC)

Mardi 26 Août 2014 - par Thuy-Linh Nguyen

IVAC VIMS Report on Global Vaccine Introduction - December 2013

Vendredi 17 Janvier 2014 - par Thuy-Linh Nguyen

International Vaccine Access Center (IVAC) Meeting 2012

Jeudi 21 Juin 2012 - par Moderator

Page 1/4

Parcourir le Forum

Membres de Technet-21

Vous devez être connecté pour voir les autres membres.

Événements à venir

Aucun événement à venir.

Offres d'emploi

Aucune offre d'emploi trouvée.

Catégories

Vaccins et dispositifs d'administration

Thèmes

Du Centre de Connaissances

Du blog

Messages de forum récents

Membres de Technet-21

Événements à venir

Offres d'emploi

À propos

Centre de connaissances

Communauté

Plus